Investigated for use/treatment in hyperlipidemia, metabolic disease, and obesity.

Investigated for use/treatment in leukemia (lymphoid) and solid tumors.

Investigated for use/treatment in leukemia (unspecified), lymphoma (unspecified), myelodysplastic syndrome, and solid tumors.

Investigated for use/treatment in traumatic brain injuries.

For the long term, once-daily-dosing maintenance of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or ...

Investigated for use/treatment in viral infection.

Investigated for use/treatment in adverse effects (chemotherapy), chemotherapy, and pancreatic cancer.

Investigated for use/treatment in neurologic disorders and schizophrenia and schizoaffective disorders.

Investigated for use/treatment in asthma and chronic obstructive pulmonary disease (COPD).

Investigated for use/treatment in diabetes mellitus type 2.

Investigated for use/treatment in obesity.

Investigated for use/treatment in pain (acute or chronic).

April 18 2007 Cortex Pharmaceuticals submitted two large data packages to the FDA regarding CX717. One data set went to the FDA's Division of Neurology Drug Products for the ...

Investigated for use/treatment in pain (acute or chronic).

Investigated for use/treatment in constipation, gastroesophageal reflux disease (GERD), gastrointestinal diseases and disorders (miscellaneous), and irritable bowel syndrome (IBS).

Investigated for use/treatment in pain (acute or chronic).

Investigated for use/treatment in breast cancer.

Investigated for use/treatment in hormone replacement therapy: menopause and menopause.

Investigated for use/treatment in diabetes mellitus type 2.

Investigated for use/treatment in acne, atopic dermatitis, pediatric indications, and psoriasis and psoriatic disorders.